| The histone methyltransferase activity of MLL1 is dispensable for hematopoiesis and leukemogenesis BP Mishra, KM Zaffuto, EL Artinger, T Org, HKA Mikkola, C Cheng, ... Cell reports 7 (4), 1239-1247, 2014 | 155 | 2014 |
| An MLL-dependent network sustains hematopoiesis EL Artinger, BP Mishra, KM Zaffuto, BE Li, EKY Chung, AW Moore, ... Proceedings of the National Academy of Sciences 110 (29), 12000-12005, 2013 | 92 | 2013 |
| Dynamic association of MLL1, H3K4 trimethylation with chromatin and Hox gene expression during the cell cycle BP Mishra, KI Ansari, SS Mandal The FEBS journal 276 (6), 1629-1640, 2009 | 87 | 2009 |
| Human CpG binding protein interacts with MLL1, MLL2 and hSet1 and regulates Hox gene expression KI Ansari, BP Mishra, SS Mandal Biochimica et Biophysica Acta (BBA)-Gene Regulatory Mechanisms 1779 (1), 66-73, 2008 | 79 | 2008 |
| MLL histone methylases in gene expression, hormone signaling and cell cycle KI Ansari, BP Mishra, SS Mandal Front Biosci 14, 3483-3495, 2009 | 65 | 2009 |
| Mixed lineage leukaemia-4 regulates cell-cycle progression and cell viability and its depletion suppresses growth of xenografted tumour in vivo KI Ansari, S Kasiri, BP Mishra, SS Mandal British journal of cancer 107 (2), 315-324, 2012 | 40 | 2012 |
| CRISPR/Cas9 Genome Editing to Treat Sickle Cell Disease and B-Thalassemia: Re-Creating Genetic Variants to Upregulate Fetal Hemoglobin Appear Well-Tolerated, Effective and Durable. MI Lin, E Paik, B Mishra, D Burkhardt, A Kernytsky, M Pettiglio, YS Chen, ... Blood 130, 284, 2017 | 20 | 2017 |
| HOXA5 expression is elevated in breast cancer and is transcriptionally regulated by estradiol I Hussain, P Deb, A Chini, M Obaid, A Bhan, KI Ansari, BP Mishra, ... Frontiers in Genetics 11, 592436, 2020 | 13 | 2020 |
| MLL1 promotes IL-7 responsiveness and survival during B cell differentiation T Gan, BE Li, BP Mishra, KL Jones, P Ernst The Journal of Immunology 200 (5), 1682-1691, 2018 | 11 | 2018 |
| Crispr/Cas9-mediated genome editing of human CD34+ cells upregulate fetal hemoglobin to clinically relevant levels in single cell-derived Erythroid Colonies B Mishra, S Chou, MI Lin, EJ Paik, Y Zhang, R Liang, K Tomkinson, ... Blood 128 (22), 3623, 2016 | 6 | 2016 |
| Re-creating hereditary persistence of fetal hemoglobin (HPFH) to treat sickle cell disease (SCD) and β-thalassemia MI Lin, EJ Paik, BP Mishra, S Chou, Y Zhang, K Tomkinson, MA Pettiglio, ... Blood 128 (22), 4708, 2016 | 4 | 2016 |
| Materials and methods for treatment of hemoglobinopathies T Chakraborty, BP Mishra, CA Cowan, AS Lundberg, S Kulkarni, ... US Patent App. 16/758,990, 2021 | 3 | 2021 |
| Compositions and methods for cd123 modification J Lydeard, C Luo, BP Mishra, M Lin US Patent App. 17/638,610, 2022 | 2 | 2022 |
| Compositions and methods for cd33 modification J Lydeard, BP Mishra US Patent App. 17/613,387, 2022 | 2 | 2022 |
| Re-creating hereditary persistence of fetal hemoglobin with CRISPR/CAS9 to treat sickle cell disease and beta-thalassemia M Lin, E Paik, B Mishra, S Chou, D Burkhardt, A Kernytsky, M Pettiglio, ... Haematologica 102, 23-24, 2017 | 1 | 2017 |
| Deconvoluting MLL1-dependent pathways in hematopoiesis and leukemogenesis BP Mishra, P Ernst Leukemia Supplements 3 (1), S9-S10, 2014 | 1 | 2014 |
| MLL1-dependent pathways and mechanisms that maintain hematopoiesis E Artinger, B Mishra, B Li, K Zaffuto, C Cheng, T Org, H Mikkola, M Djabali, ... Experimental Hematology 41 (8), S20, 2013 | 1 | 2013 |
| Materiaaleja ja menetelmiä hemoglobinopatioiden hoitamiseksi C Cowan, A Lundberg, T Chakraborty, M Lin, B Mishra, E Paik, ... | | 2024 |
| Materials and methods for treatment of hemoglobinopathies T Chakraborty, BP Mishra US Patent App. 17/585,365, 2022 | | 2022 |
| Materials and methods for treatment of hemoglobinopathies CA Cowan, AS Lundberg, T Chakraborty, I Michelle, LIN Ching, ... US Patent App. 17/591,563, 2022 | | 2022 |
Khairul AnsariCity of Hope National Medical Center, Harvard Medical School-Harvard University, The在 partners.org 的电子邮件经过验证
